IVZ vs SOLV · rev $3.57B vs P/E 9.1, rev $8.32B
Invesco Plc (IVZ) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
IVZ currently screens at market cap $12.76B. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the IVZ and SOLV stock pages for the full models.
Not investment advice.